{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-069070","form_type":"8-K","ticker":"BDTX","cik":"0001701541","company_name":"Black Diamond Therapeutics, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.653101+00:00","generated_at":"2026-06-01T05:56:18.867117+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Black Diamond Therapeutics shareholders approve officer liability limitation and elect directors","bullets":["Shareholders approved Amendment to limit officer liability as permitted by Delaware law.","Prakash Raman and Mark A. Velleca elected as Class I directors to serve until 2027.","PricewaterhouseCoopers LLP ratified as independent auditor for FY2024.","Certificate of Amendment filed and effective June 6, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-069070","json":"https://secwatch.observer/filing/0001104659-24-069070.json","markdown":"https://secwatch.observer/filing/0001104659-24-069070.md","text":"https://secwatch.observer/filing/0001104659-24-069070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701541/000110465924069070/0001104659-24-069070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701541/000110465924069070/tm2416636d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:56:18.867117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}